Xcellerant Ventures Backs CRISPR QC in Series A and Commercial Expansion
SAN DIEGO–(BUSINESS WIRE)–CRISPR QC, a biotechnology start-up based in San Diego, is pleased to announce a major stride in its ongoing Series A funding round. Known for their CRISPR Analytics Platform, powered by the CRISPR-Chip, CRISPR QC analyzes and optimizes aspects of CRISPR editing before cell work, enabling researchers to save valuable time, money, and resources.
